SG11201803584RA - 1,4-dicarbonyl-piperidyl derivatives - Google Patents

1,4-dicarbonyl-piperidyl derivatives

Info

Publication number
SG11201803584RA
SG11201803584RA SG11201803584RA SG11201803584RA SG11201803584RA SG 11201803584R A SG11201803584R A SG 11201803584RA SG 11201803584R A SG11201803584R A SG 11201803584RA SG 11201803584R A SG11201803584R A SG 11201803584RA SG 11201803584R A SG11201803584R A SG 11201803584RA
Authority
SG
Singapore
Prior art keywords
dicarbonyl
piperidyl derivatives
piperidyl
derivatives
Prior art date
Application number
SG11201803584RA
Other languages
English (en)
Inventor
Hans-Peter Buchstaller
Dieter Dorsch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SG11201803584RA publication Critical patent/SG11201803584RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201803584RA 2015-11-02 2016-10-07 1,4-dicarbonyl-piperidyl derivatives SG11201803584RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15192489 2015-11-02
PCT/EP2016/001668 WO2017076484A1 (en) 2015-11-02 2016-10-07 1,4-dicarbonyl-piperidyl derivatives

Publications (1)

Publication Number Publication Date
SG11201803584RA true SG11201803584RA (en) 2018-05-30

Family

ID=54365114

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201803584RA SG11201803584RA (en) 2015-11-02 2016-10-07 1,4-dicarbonyl-piperidyl derivatives

Country Status (14)

Country Link
US (1) US10570116B2 (zh)
EP (1) EP3371166B1 (zh)
JP (1) JP6885962B2 (zh)
KR (1) KR20180073681A (zh)
CN (1) CN108137556B (zh)
AU (1) AU2016349148C1 (zh)
BR (1) BR112018007358A2 (zh)
CA (1) CA3003600A1 (zh)
ES (1) ES2773511T3 (zh)
IL (1) IL258977B (zh)
MX (1) MX2018005515A (zh)
RU (1) RU2018119935A (zh)
SG (1) SG11201803584RA (zh)
WO (1) WO2017076484A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019084060A1 (en) 2017-10-24 2019-05-02 Silverback Therapeutics, Inc. CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
EP3891136B1 (en) * 2018-12-03 2023-07-19 Merck Patent GmbH 4-heteroarylcarbonyl-n-(phenyl or heteroaryl)piperidine-1-carboxamides as inhibitors of tankyrases
BR112022008282A2 (pt) * 2019-10-30 2022-07-26 Digmbio Inc Derivados de isoquinolinona, método para preparar os mesmos e composição farmacêutica para prevenir ou tratar doenças relacionadas à poli(adp-ribose) polimerase-1, que compreendem os mesmos como ingrediente ativo
CN116143743A (zh) * 2023-01-08 2023-05-23 太仓市茜泾化工有限公司 一种3-异丁基戊二酸酐的制备工艺及其制备装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5957077B2 (ja) * 2011-07-13 2016-07-27 ノバルティス アーゲー タンキラーゼ阻害剤として使用するための4−ピペリジニル化合物
EP2731942B1 (en) * 2011-07-13 2015-09-23 Novartis AG Novel 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
US9505749B2 (en) * 2012-08-29 2016-11-29 Amgen Inc. Quinazolinone compounds and derivatives thereof
HUE032846T2 (en) 2013-07-31 2017-11-28 Merck Patent Gmbh Oxokinazolinil-butanamide derivatives
KR102415436B1 (ko) 2014-05-07 2022-06-30 메르크 파텐트 게엠베하 헤테로시클릴-부탄아미드 유도체

Also Published As

Publication number Publication date
IL258977B (en) 2020-06-30
WO2017076484A1 (en) 2017-05-11
EP3371166B1 (en) 2019-11-20
IL258977A (en) 2018-06-28
ES2773511T3 (es) 2020-07-13
AU2016349148B2 (en) 2021-05-13
BR112018007358A2 (pt) 2018-10-23
US10570116B2 (en) 2020-02-25
JP2019501954A (ja) 2019-01-24
CN108137556A (zh) 2018-06-08
MX2018005515A (es) 2018-08-01
CN108137556B (zh) 2021-07-30
AU2016349148A1 (en) 2018-06-14
CA3003600A1 (en) 2017-05-11
US20190092751A1 (en) 2019-03-28
KR20180073681A (ko) 2018-07-02
RU2018119935A (ru) 2019-12-04
AU2016349148C1 (en) 2021-08-26
EP3371166A1 (en) 2018-09-12
JP6885962B2 (ja) 2021-06-16

Similar Documents

Publication Publication Date Title
IL288232A (en) 1,7- naphthyridine as immunomodulators
IL264092A (en) 1, 3-dihydroxy-phenyl derivatives are useful as immunomodulators
HK1255045A1 (zh) 取代的氧代吡啶衍生物
HK1254654A1 (zh) 4,6-亞嘧啶基衍生物及其用途
GB201507594D0 (en) Intamac 1
IL253381A0 (en) History of h9-pyrrolo-dipyridine
IL271607A (en) New azaquinoline histories
HK1245258A1 (zh) 新的二氟酮酰胺衍生物
SG11201803584RA (en) 1,4-dicarbonyl-piperidyl derivatives
IL251005B (en) Pyrido-oxazinone derivatives
HK1254800A1 (zh) 2,3,4,5-四氫吡啶-6-胺衍生物
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
AU5457P (en) JOAe 6656 Aeonium arborium
PT3319956T (pt) Derivados de oxopiridina substituída
GB201519732D0 (en) Mrbr.2
GB201519992D0 (en) Pantrap Nov 2015
GB201521485D0 (en) .
GB201518402D0 (en) Products, uses & methods (8)
GB201513785D0 (en) Aerocar 1
GB201513303D0 (en) Kapiche 1
GB201516063D0 (en) The microsecurity
GB201510891D0 (en) Products, uses & methods (7)
GB201509410D0 (en) Tidysqueeze 4
GB201515401D0 (en) The gastro-sock
GB201509366D0 (en) Products, uses & methods (6)